The adaptive immune system in early life: The shift makes it count

Area of Science:

• Immunology
• Pediatrics
• Vaccinology

Background:

• Neonatal immune systems are naive, increasing susceptibility to life-threatening respiratory infections.
• While vaccines reduce childhood mortality, infant vaccination requires repeated doses and wanes faster than in adults.
• The infant immune system, once considered immature, now shows evidence of strong innate-like effector functions and a tolerogenic counterpart.

Purpose of the Study:

• To review recent literature on the adaptive immune system in early life.
• To explore how innate-like and tolerogenic features influence infant immune responses to vaccination.
• To propose the use of these immune features as biomarkers for improved infant vaccination strategies.

Main Methods:

• Literature review of recent studies on early life adaptive immunity.
• Analysis of the interplay between innate-like effector functions and tolerogenic mechanisms.
• Speculation on the developmental shift from innate-like/tolerogenic immunity to immune memory.

Main Results:

• The early life adaptive immune system exhibits potent innate-like effector functions for pathogen clearance.
• A tolerogenic arm of the adaptive system balances these effector functions to prevent damage.
• A developmental shift occurs from these early features towards immune memory formation.

Conclusions:

• The efficacy of infant vaccination may vary depending on the phase of immune development (innate-like, tolerogenic, or memory-focused).
• Identifying innate-like and tolerogenic immune features could serve as biomarkers.
• These biomarkers may enable the optimization of vaccination strategies for infants, enhancing protection against respiratory and other infections.